Published in Microbiology on May 01, 2000
Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone. Infect Immun (2001) 5.27
Molecular genetic analysis of a group A Streptococcus operon encoding serum opacity factor and a novel fibronectin-binding protein, SfbX. J Bacteriol (2003) 2.38
Genome sequence of a nephritogenic and highly transformable M49 strain of Streptococcus pyogenes. J Bacteriol (2008) 1.67
Group G streptococcal bacteremia in Jerusalem. Emerg Infect Dis (2004) 1.62
M types of group a streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999. J Clin Microbiol (2002) 1.51
Group A streptococcal genotypes from pediatric throat isolates in Rome, Italy. J Clin Microbiol (2001) 1.38
Epidemiologic analysis of invasive and noninvasive group a streptococcal isolates in Hong Kong. J Clin Microbiol (2003) 1.34
Population biology of the human restricted pathogen, Streptococcus pyogenes. Infect Genet Evol (2009) 1.27
Genetic relationships deduced from emm and multilocus sequence typing of invasive Streptococcus dysgalactiae subsp. equisimilis and S. canis recovered from isolates collected in the United States. J Clin Microbiol (2009) 1.20
Genetically diverse group A streptococci from children in far-western Nepal share high genetic relatedness with isolates from other countries. J Clin Microbiol (2006) 1.14
Erythromycin-resistant pharyngeal isolates of Streptococcus pyogenes recovered in Italy. Antimicrob Agents Chemother (2002) 1.04
Tissue tropisms in group A streptococcal infections. Future Microbiol (2010) 1.03
Clostridium difficile genotyping based on slpA variable region in S-layer gene sequence: an alternative to serotyping. J Clin Microbiol (2002) 1.01
Genetic and phenotypic features of Streptococcus pyogenes strains isolated in Brazil that harbor new emm sequences. J Clin Microbiol (2001) 1.00
Molecular epidemiology and genomics of group A Streptococcus. Infect Genet Evol (2014) 1.00
emm Gene distribution among erythromycin-resistant and -susceptible Italian isolates of Streptococcus pyogenes. J Clin Microbiol (2003) 0.99
Six-month multicenter study on invasive infections due to Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis in Argentina. J Clin Microbiol (2005) 0.97
Erythromycin-resistant group A streptococcal isolates recovered in Sofia, Bulgaria, from 1995 to 2001. J Clin Microbiol (2002) 0.97
Deriving group A Streptococcus typing information from short-read whole-genome sequencing data. J Clin Microbiol (2014) 0.95
High Incidence of Invasive Group A Streptococcus Disease Caused by Strains of Uncommon emm Types in Thunder Bay, Ontario, Canada. J Clin Microbiol (2015) 0.95
Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci. Infect Immun (2003) 0.89
Function of the fibronectin-binding serum opacity factor of Streptococcus pyogenes in adherence to epithelial cells. Infect Immun (2004) 0.88
International quality assurance study for characterization of Streptococcus pyogenes. J Clin Microbiol (2007) 0.86
Two cases and a review of Streptococcus pyogenes endocarditis in children. BMC Pediatr (2014) 0.82
The structure and function of serum opacity factor: a unique streptococcal virulence determinant that targets high-density lipoproteins. J Biomed Biotechnol (2010) 0.81
Mass antibiotic treatment for group A streptococcus outbreaks in two long-term care facilities. Emerg Infect Dis (2003) 0.80
Genetic analysis of group A streptococcus isolates recovered during acute glomerulonephritis outbreaks in Guizhou Province of China. J Clin Microbiol (2008) 0.79
Detecting key structural features within highly recombined genes. PLoS Comput Biol (2007) 0.77
Emergence of Streptococcus pyogenes emm102 causing toxic shock syndrome in Southern Taiwan during 2005-2012. PLoS One (2013) 0.75
Invasive group A streptococcal disease: Management and chemoprophylaxis. Paediatr Child Health (2010) 0.75
Rapid Emergence of a New Clone Impacts the Population at Risk and Increases the Incidence of Type emm89 Group A Streptococcus Invasive Disease. Open Forum Infect Dis (2017) 0.75
Invasive group A streptococcal disease: Management and chemoprophylaxis. Can J Infect Dis Med Microbiol (2010) 0.75
Clustered Regularly Interspaced Short Palindromic Repeats Are emm Type-Specific in Highly Prevalent Group A Streptococci. PLoS One (2015) 0.75
Population and Whole Genome Sequence Based Characterization of Invasive Group A Streptococci Recovered in the United States during 2015. MBio (2017) 0.75
High Incidence of Invasive Group A Streptococcal Infections in Remote Indigenous Communities in Northwestern Ontario, Canada. Open Forum Infect Dis (2016) 0.75
An emm5 Group A Streptococcal Outbreak Among Workers in a Factory Manufacturing Telephone Accessories. Front Microbiol (2017) 0.75
Towards developing a vaccine for rheumatic heart disease. Glob Cardiol Sci Pract (2017) 0.75
Recognition of group D streptococcal species of human origin by biochemical and physiological tests. Appl Microbiol (1972) 13.09
Physiological differentiation of viridans streptococci. J Clin Microbiol (1977) 11.17
Presumptive identification of group A, B, and D streptococci. Appl Microbiol (1974) 8.23
Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis). Infect Immun (1973) 7.01
Emergence of drug-resistant pneumococcal infections in the United States. JAMA (1994) 6.29
Comparison of several laboratory media for presumptive identification of enterococci and group D streptococci. Appl Microbiol (1973) 6.17
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis (1983) 6.15
Presumptive identification of group D streptococci: the bile-esculin test. Appl Microbiol (1970) 6.00
Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol (1988) 5.71
The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med (1995) 5.18
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet (1999) 4.38
Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group. J Infect Dis (1991) 4.00
Nonhemolytic group B streptococci of human, bovine, and ichthyic origin. Infect Immun (1973) 3.81
Changing epidemiology of group A streptococcal infection in the USA. Lancet (1990) 3.35
Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA (1993) 3.31
The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis (1996) 3.26
Phylogenetic analysis of some Aerococcus-like organisms from clinical sources: description of Helcococcus kunzii gen. nov., sp. nov. Int J Syst Bacteriol (1993) 3.16
Evaluation of the Rapid Strep system for the identification of clinical isolates of Streptococcus species. J Clin Microbiol (1984) 3.16
emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis (1999) 3.12
Antibiotic susceptibility of Streptococcus bovis and other group D streptococci causing endocarditis. Antimicrob Agents Chemother (1974) 3.06
Antibiotics synergism: enhanced susceptibility of group D streptococci to certain antibiotic combinations. Antimicrob Agents Chemother (Bethesda) (1970) 3.05
The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis (1992) 3.04
Evaluation of commercial latex agglutination reagents for grouping streptococci. J Clin Microbiol (1979) 2.95
Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis (1996) 2.85
Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med (1980) 2.85
Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis (1990) 2.80
Presumptive identification of group A, B, and D streptococci on agar plate media. J Clin Microbiol (1979) 2.72
Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan. Lancet (1991) 2.63
Presumptive identification of streptococci with a new test system. J Clin Microbiol (1982) 2.55
Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem? J Clin Microbiol (1989) 2.51
Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study--1996. Sentinel Health Unit Surveillance System Site Coordinators. J Infect Dis (2000) 2.41
Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA (2001) 2.40
Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun (1993) 2.32
Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli. Nature (1992) 2.32
Pneumococcal vaccine efficacy in selected populations in the United States. Ann Intern Med (1986) 2.26
Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group. J Clin Microbiol (1992) 2.23
Possible nosocomial transmission of group B streptococci in a newborn nursery. J Pediatr (1975) 2.21
Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J Pediatr (1996) 2.17
Granulicatella and Abiotrophia species from human clinical specimens. J Clin Microbiol (2001) 2.14
Specificity study of kits for detection of group A streptococci directly from throat swabs. J Clin Microbiol (1987) 2.10
Rapid identification of enterococci. J Clin Microbiol (1983) 2.03
Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species. Antimicrob Agents Chemother (1990) 1.93
Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine. J Infect Dis (1995) 1.93
Phenotypic and genotypic characterization of atypical Lactococcus garvieae strains isolated from water buffalos with subclinical mastitis and confirmation of L. garvieae as a senior subjective synonym of Enterococcus seriolicida. Int J Syst Bacteriol (1996) 1.92
Differentiation of Lactococcus lactis and Lactococcus garvieae from humans by comparison of whole-cell protein patterns. J Clin Microbiol (1991) 1.91
The gram positive cocci. Hum Pathol (1976) 1.90
Neonatal enterococcal sepsis: case-control study and description of an outbreak. Pediatr Infect Dis J (1987) 1.89
A review of the microbiological techniques for the isolation and identification of streptococci. CRC Crit Rev Clin Lab Sci (1976) 1.84
Streptococcus faecium outbreak in a neonatal intensive care unit. J Clin Microbiol (1984) 1.81
Correlation between phenotypic characteristics and DNA relatedness within Enterococcus faecium strains. J Clin Microbiol (1995) 1.79
Comparison of three commercial rapid identification systems for the unusual gram-positive cocci Dolosigranulum pigrum, Ignavigranum ruoffiae, and Facklamia species. J Clin Microbiol (2000) 1.78
Vancomycin-resistant Pediococcus acidilactici: nine cases of bacteremia. J Infect Dis (1990) 1.75
Streptococcus iniae, a human and animal pathogen: specific identification by the chaperonin 60 gene identification method. J Clin Microbiol (1998) 1.75
Antimicrobial susceptibility patterns of Streptococcus pneumoniae. Antimicrob Agents Chemother (1978) 1.75
An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. N Engl J Med (1994) 1.73
Atmospheric growth requirements for Alloiococcus species and related gram-positive cocci. J Clin Microbiol (1996) 1.72
Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (2001) 1.69
Major related sets of antibiotic-resistant Pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles. J Infect Dis (2000) 1.69
Enterococcus raffinosus sp. nov., Enterococcus solitarius sp. nov. and Enterococcus pseudoavium sp. nov. FEMS Microbiol Lett (1989) 1.67
Nosocomial transmission of group B streptococci. Pediatrics (1976) 1.62
Sudden increase in isolation of group B streptococci, serotype V, is not due to emergence of a new pulsed-field gel electrophoresis type. J Clin Microbiol (1998) 1.61
Physiological characterization of nutritionally variant streptococci. J Clin Microbiol (1979) 1.57
Antimicrobial susceptibilities of Lactococcus lactis and Lactococcus garvieae and a proposed method to discriminate between them. J Clin Microbiol (1996) 1.57
Identification and characterization of IS1476, an insertion sequence-like element that disrupts VanY function in a vancomycin-resistant Enterococcus faecium strain. Antimicrob Agents Chemother (1997) 1.56
Streptococcal emm types associated with T-agglutination types and the use of conserved emm gene restriction fragment patterns for subtyping group A streptococci. J Med Microbiol (1998) 1.54
Rapid group A streptococcal antigen detection kit: effect on antimicrobial therapy for acute pharyngitis. Pediatrics (1988) 1.49
Enterococcus spp. produces slime and survives in rat peritoneal macrophages. Med Microbiol Immunol (2001) 1.47
Capillary precipitin typing of Streptococcus pneumoniae. J Clin Microbiol (1978) 1.47
Breast abscess associated with Helcococcus kunzii. J Clin Microbiol (1998) 1.43
Primary invasive Haemophilus influenzae type b disease: a population-based assessment of risk factors. J Pediatr (1986) 1.40
Phenotypic and genotypic characterization of Vagococcus fluvialis, including strains isolated from human sources. J Clin Microbiol (1997) 1.40
Globicatella sanguis gen.nov., sp.nov., a new gram-positive catalase-negative bacterium from human sources. J Appl Bacteriol (1992) 1.39
Group A streptococcal genotypes from pediatric throat isolates in Rome, Italy. J Clin Microbiol (2001) 1.38
Description of Gemella sanguinis sp. nov., isolated from human clinical specimens. J Clin Microbiol (1998) 1.35
Viridans streptococcal endocarditis: clinical, microbiological, and echocardiographic correlations. J Infect Dis (1986) 1.35
Identification of Enterococcus species and phenotypically similar Lactococcus and Vagococcus species by reverse checkerboard hybridization to chaperonin 60 gene sequences. J Clin Microbiol (2000) 1.34
Genetic relationships among the different phenotypes of Streptococcus dysgalactiae strains. Int J Syst Bacteriol (1998) 1.32
From the center for disease control. Epidemiology of pneumococcal serotypes in the United States, 1978--1979. J Infect Dis (1980) 1.32
Whole-cell protein patterns of nonhemolytic group B, type Ib, streptococci isolated from humans, mice, cattle, frogs, and fish. J Clin Microbiol (1990) 1.32
Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury. Am J Kidney Dis (2000) 1.31
Gemella bergeriae sp. nov., isolated from human clinical specimens. J Clin Microbiol (1998) 1.30
Epidemiology of clinically significant isolates of Streptococcus pneumoniae in the United States. Rev Infect Dis (1981) 1.30
Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococci. Antimicrob Agents Chemother (1981) 1.28
Risk factors for pulmonary embolism. The Framingham Study. Am J Med (1983) 1.28
Modified culture technique for Corynebacterium diphtheriae isolation from desiccated swabs. J Clin Microbiol (1978) 1.28
Evaluation of the Directigen Group A Strep test kit. J Clin Microbiol (1984) 1.26
Molecular analysis of the genetic variation among penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae serotypes in Canada. J Infect Dis (1999) 1.26
Facklamia ignava sp. nov., isolated from human clinical specimens. J Clin Microbiol (1998) 1.26
Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group. JAMA (1996) 1.26
Clusters of invasive group A streptococcal infections in family, hospital, and nursing home settings. Clin Infect Dis (1992) 1.25
The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis (1990) 1.25
Distribution of serotypes and antimicrobial resistance of Streptococcus pneumoniae strains isolated in Brazil from 1988 to 1992. J Clin Microbiol (1994) 1.25
Guanidine extraction of streptococcal M protein. Infect Immun (1975) 1.25
Susceptibility of relatively penicillin-resistant Streptococcus pneumoniae to newer cephalosporin antibiotics. Diagn Microbiol Infect Dis (1987) 1.25
Phenotypic characterization, cellular fatty acid composition, and DNA relatedness of aerococci and comparison to related genera. J Clin Microbiol (1990) 1.24
Recent approaches on the taxonomy of the enterococci and some related microorganisms. Adv Exp Med Biol (1997) 1.24
Enterococcus dispar sp. nov. a new Enterococcus species from human sources. Lett Appl Microbiol (1991) 1.22